title: Total and partial cancer prevalence in the adult French population in 2008.
abstract: BACKGROUND
  To provide estimations of partial and total prevalence of 24 cancer sites in France in 2008. The estimations of partial prevalence were compared with the previous estimations for 2002.
  
  
  METHODS
  Nationwide estimations of incidence and survival data from cancer registries were used for partial prevalence. Nationwide incidence and mortality data were used to estimate total prevalence.
  
  
  RESULTS
  At the end of 2008, in France, nearly 3 million people still alive had received a diagnosis of cancer. Of all prevalent cases, 36% were diagnosed 0 to 5 years earlier and 43% diagnosed 6 to 10 years earlier. The cancer sites with the highest prevalence were the prostate, the breast, and the colon-rectum. The changes in partial prevalence over 5 years (2002 to 2008) were considerable (+244,000 cases) and deemed to be highly related to changes in incidence.
  
  
  CONCLUSIONS
  The present estimations update the French prevalence data and highlight the burden of cancer in the population, especially in the elderly. The methods of this study had the advantage of using recent incidence and survival data, which is necessary to show sudden changes in incidence trends and changes in survival that impact prevalence.
authors.affiliation: Isère Cancer Registry, F-38043, Grenoble, France. mcolonna.registre@wanadoo.fr.|FRANCIM, F-31073, Toulouse, France. mcolonna.registre@wanadoo.fr.
authors.forename: Marc
authors.initials: M
authors.lastname: Colonna
authors.affiliation: Isère Cancer Registry, F-38043, Grenoble, France. NMitton@chu-grenoble.fr.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Mitton
authors.affiliation: Service de Biostatistique, Hospices Civils de Lyon, F-69003, Lyon, France. nadine.bossard@chu-grenoble.fr.|Université Lyon 1, F-69100, Lyon, France. nadine.bossard@chu-grenoble.fr.|Université de Lyon, F-69000, Lyon, France. nadine.bossard@chu-grenoble.fr.|CNRS UMR 5558, Equipe Biostatistique Santé, F-69310, Pierre-Bénite, France. nadine.bossard@chu-grenoble.fr.
authors.forename: Nadine
authors.initials: N
authors.lastname: Bossard
authors.affiliation: Service de Biostatistique, Hospices Civils de Lyon, F-69003, Lyon, France. Aurelien.Belot@lshtm.ac.uk.|Université Lyon 1, F-69100, Lyon, France. Aurelien.Belot@lshtm.ac.uk.|Université de Lyon, F-69000, Lyon, France. Aurelien.Belot@lshtm.ac.uk.|CNRS UMR 5558, Equipe Biostatistique Santé, F-69310, Pierre-Bénite, France. Aurelien.Belot@lshtm.ac.uk.|Institut de Veille Sanitaire, Département des Maladies Chroniques et Traumatismes, F-94410, Saint-Maurice, France. Aurelien.Belot@lshtm.ac.uk.|Cancer Research UK Cancer Survival Group, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK. Aurelien.Belot@lshtm.ac.uk.
authors.forename: Aurelien
authors.initials: A
authors.lastname: Belot
authors.affiliation: Tarn Cancer Registry, F-81000, Albi, France. pascale.grosclaude@inserm.fr.
authors.forename: Pascale
authors.initials: P
authors.lastname: Grosclaude
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005602:France / Q000453:epidemiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000175:diagnosis* / Q000453:epidemiology*; D011159:Population Surveillance / Q000379:methods; D015995:Prevalence; D012042:Registries; D055815:Young Adult